Kyntra Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Kyntra Bio (Nasdaq: KYNB) announced management will participate in investor conferences in February–March 2026. Presentations: Oppenheimer 36th Annual Healthcare Life Sciences (virtual, Feb 26, 2026, 2:40–3:10 PM ET) and Leerink Global Healthcare Conference (Miami, Mar 11, 2026, 2:20–2:50 PM ET).

Management will be available for one-on-one meetings; webcasts are provided and presentation replays will be posted on the company's Events & Presentations investor page for 90 days.

News Market Reaction – KYNB

-1.61%

4 alerts

-1.61% News Effect

+2.4% Peak Tracked

-$528K Valuation Impact

$32M Market Cap

0.4x Rel. Volume

On the day this news was published, KYNB declined 1.61%, reflecting a mild negative market reaction. Argus tracked a peak move of +2.4% during that session. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $528K from the company's valuation, bringing the market cap to $32M at that time.

Data tracked by StockTitan Argus on the day of publication.

SAN FRANCISCO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), today announced that the company’s management will participate in the following investor conferences:

Oppenheimer 36th Annual Healthcare Life Sciences Conference
Format: Corporate Presentation
Date & Time: Thursday, February 26, 2026, 2:40-3:10 PM ET
Location: Virtual
Webcast: https://event.summitcast.com/view/

Leerink Global Healthcare Conference
Format: Corporate Presentation
Date & Time: Wednesday, March 11, 2026, 2:20-2:50 PM ET
Location: Miami, FL
Webcast: https://event.summitcast.com/view/

Kyntra Bio’s management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representatives to request a meeting. A replay of the presentations will be posted, when available, to the Kyntra Bio website on the Events & Presentations page of the Investors and Media section for 90 days.

About Kyntra Bio
Kyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Roxadustat (爱瑞卓^®, EVRENZO™) is currently approved in Europe, Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. The Company continues to evaluate the development plan for the Phase 3 trial of roxadustat in anemia associated with lower-risk myelodysplastic syndromes (LR-MDS) in the U.S. FG-3246 (also known as FOR46), a first-in-class antibody-drug conjugate (ADC) targeting CD46, is in Phase 2 development for the treatment of metastatic castration-resistant prostate cancer. This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker. For more information, please visit www.kyntrabio.com.

For Investor Inquiries:
David DeLucia, CFA
Senior Vice President and Chief Financial Officer
ir@kyntrabio.com 

FAQ

When will Kyntra Bio (KYNB) present at the Oppenheimer Healthcare Life Sciences Conference?

Kyntra Bio will present on Thursday, February 26, 2026 from 2:40–3:10 PM ET. According to the company, the session is a corporate presentation delivered virtually with a webcast link provided for live viewing.

What are the details for Kyntra Bio's (KYNB) Leerink Global Healthcare Conference presentation?

Kyntra Bio will present on Wednesday, March 11, 2026 from 2:20–2:50 PM ET in Miami, FL. According to the company, this is a corporate presentation and management will offer one-on-one meetings during the conference.

Will Kyntra Bio (KYNB) offer replays of its investor presentations and for how long?

Yes, presentation replays will be posted to Kyntra Bio's investor Events & Presentations page for 90 days. According to the company, replays will be available when posted following each conference presentation.

How can investors request one-on-one meetings with Kyntra Bio (KYNB) management at the conferences?

Investors should contact their conference representatives to request one-on-one meetings with Kyntra Bio management. According to the company, interested investors must coordinate through their respective conference or broker contacts.

Where can I watch the live webcast of Kyntra Bio's (KYNB) conference presentations?

Live webcasts are available via the event webcast links provided for each conference. According to the company, the Oppenheimer and Leerink sessions include webcast URLs for live viewing and later replay.